摘要 |
The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of a compound represented by the general formula I, wherein hatched lines represent the alpha configuration, a triangle represents the beta configuration and a dotted line represents the presence or absence of a double bond; A and B are independently selected from the group consisting of O, S and CH2 provided that at least one of A or B is S; D represents a covalent bond or CH2, O, S or NH; X is CO2R, CONR2, CH2OR, P(O)(OR)2, CONRSO2R SONR2 or Y is O, OH, OCOR<2>, halogen or cyano; Z is CH2 or a covalent bond; R is H or R<2>; R<1> is H, R<2>, phenyl, or COR<2>; R<2> is C1-C5 lower alkyl and R3 is C1-C5 n-alkyl, C3-C7 cycloalkyl, phenyl, furanyl, thienyl, or substituted derivatives thereof, wherein the substituents may be selected from the group consisting of C1-C5 alkyl, halogen, CF3, CN, NO2, CO2R and OR. |
申请人 |
ALLERGAN, INC.;BURK, ROBERT, M.;HOLOBOSKI, MARK;POSNER, MARI, F. |
发明人 |
BURK, ROBERT, M.;HOLOBOSKI, MARK;POSNER, MARI, F. |